Skip to main content

DIADEMA PARTNERS LP

Position in CAPR — Capricor Therapeutics, Inc.

CIK 2026172 MORRISTOWN, NJ

Position in CAPR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$2,397,070 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2024
7 quarters on record

Common Shares in CAPR Over Time

Shares Held

Position Value (USD)

Derivatives in CAPR

reported options exposure · as of Jun 30, 2026
CallValue
$7,929,544
CallShares
329,300
PutValue
$12,868,352
PutShares
534,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

DIADEMA PARTNERS LP holds $217,374,297 across 66 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CAPR

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,868,352 534,400
2026-06-30 $7,929,544 329,300
2026-03-31 $10,010,720 329,300
2026-03-31 $18,951,360 623,400
2026-03-31 $2,397,070 78,851
2025-12-31 $9,012,978 312,300
2025-12-31 $4,562,044 158,075
2025-12-31 $5,772,000 200,000
2025-09-30 $2,163,000 300,000
2025-06-30 $1,058,538 106,600
2025-03-31 $287,547 30,300
2024-12-31 $810,060 58,700
2024-12-31 $2,760,000 200,000